OEM/ODM Nucleic Acid Testing Solutions Manufacturer & Factory

Advanced Molecular Diagnostic Systems, Precision Genetic Testing, and Global Scale IVD Manufacturing Excellence

Corporate Authority & Innovation DNA

Shenzhen BioX Medical Co., Ltd. stands as a preeminent global manufacturer specializing in the end-to-end development of molecular diagnostic analysis systems, genetic testing solutions, and sophisticated clinical laboratory equipment. Established in 2017, BioX Medical is strategically headquartered in Shenzhen, China—the world’s epicenter for biotechnological innovation, high-tech medical device development, and precision advanced manufacturing.

Operating from a state-of-the-art facility spanning over 9,000 square meters with a dedicated workforce of 200+ elite professionals, we provide the global healthcare infrastructure with the analytical tools required for the 21st century. Our mission is to bridge the gap between complex genetic data and actionable clinical insights through automation, accuracy, and accessibility.

9,000+

SQM Factory

2017

Established

60+

Countries Served

ISO

Certified Quality

🌐

Global Procurement Demand for NAT Solutions

Clinical Diagnostics

Hospitals and reference labs require high-throughput PCR systems to manage the increasing volume of infectious disease screening and personalized oncology testing.

Public Health Security

Government agencies are investing in decentralized, portable pathogen detection systems for rapid response to biothreats and regional outbreaks.

Agriculture & Breeding

Genetic testing solutions are now vital for livestock pedigree verification, disease resistance screening, and high-yield crop development.

Industrial Bio-Manufacturing

Companies require real-time monitoring of microbial contamination in pharmaceutical and food production lines using automated nucleic acid platforms.

🔬

Technical Roadmap & Future Outlook

The Evolution of PCR and Beyond

The roadmap for Nucleic Acid Testing (NAT) is shifting from basic amplification to integrated "Sample-to-Answer" ecosystems. BioX Medical is at the forefront of this transition, focusing on three core pillars:

  • Miniaturization & POCT: Transitioning laboratory-grade sensitivity to portable devices that can be operated in field conditions without complex infrastructure.
  • Digital PCR (dPCR): Moving towards absolute quantification for liquid biopsy and rare mutation detection, providing a level of precision that traditional qPCR cannot match.
  • AI-Driven Interpretation: Utilizing machine learning algorithms to automate the interpretation of complex fluorescent curves, reducing human error and increasing diagnostic confidence.

Looking toward 2030, the integration of CRISPR-based diagnostics and rapid isothermal amplification (LAMP) will redefine the speed of molecular testing. BioX Medical's R&D department is actively prototyping hybrid systems that combine the gold-standard accuracy of PCR with the speed of next-generation chemical modalities.

⚙️

Scalable OEM/ODM Manufacturing Excellence

Custom Hardware Design

From PCB layout to industrial aesthetics, we tailor the hardware to match your brand identity and functional requirements.

Reagent Compatibility

Our open-platform systems are optimized for a wide range of extraction and amplification chemistries, ensuring flexibility for reagent partners.

Software White-Labeling

Full GUI customization and LIS integration support, allowing your laboratory software to communicate seamlessly with our hardware.

Shenzhen BioX Medical provides a robust framework for distributors and diagnostic companies seeking customized solutions. Our multidisciplinary team of engineers ensures that every OEM project adheres to strict International Industry Standards (ISO 13485), providing consistent performance across diverse global markets, including Europe, North America, and the Asia-Pacific.

🛡️

Localization & Compliance Support

Navigating the regulatory landscape of In Vitro Diagnostics (IVD) is a critical challenge for global expansion. BioX Medical provides comprehensive support for:

Regulatory Documentation

Providing technical files for CE-IVD, FDA 510(k), and NMPA registrations.

Quality Control (QC)

Every unit undergoes multi-stage inspection, including thermal cycler uniformity and optical sensitivity verification.

Local Logistics

Optimized cold-chain compatibility and localized technical training for distributors in over 60 countries.

Frequently Asked Questions (FAQ)

Q: What is the typical lead time for an OEM PCR system order?
A: For standard hardware modifications, the lead time ranges from 8-12 weeks. Fully custom ODM designs involving new mold creation may take 6-9 months depending on regulatory requirements.
Q: Do your nucleic acid testing solutions support open-system reagents?
A: Yes, most of our platforms, including the Tianlong Gentier and Biobase series, are designed as open systems, allowing compatibility with most commercial fluorescent quantitative PCR kits.
Q: How does BioX Medical ensure the accuracy of portable pathogen detection?
A: Our portable systems utilize the same high-sensitivity optical sensors found in benchtop models, combined with sophisticated temperature control algorithms to ensure laboratory-grade results in the field.
Q: Is technical training provided for international distributors?
A: Absolutely. We provide comprehensive online and on-site training programs covering installation, routine maintenance, and troubleshooting for all our molecular diagnostic platforms.